These results clarify the mechanisms underlying the phenotypic expression associated with PLA2G6 mutations; selective effects on protein function, rather than other genetic or environmental factors, produce the two different disease spectrums, NBIA/INAD and dystonia-parkinsonism. This evidence concerns the gene PLA2G6 and Parkinson disease.